Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide.

BACKGROUND Carbon monoxide (CO), like nitric oxide (NO), stimulates soluble guanylyl cyclase and thereby raises intracellular levels of cGMP. We examined the endogenous capacity of vascular smooth muscle cells (SMCs) to produce CO from heme through the activity of heme oxygenases. METHODS AND RESULTS Cultured SMCs from rat aorta (RASMCs) expressed immunoreactive inducible heme oxygenase-1 (HO-1) and constitutive HO-2. Treatment of RASMCs with hemin and sodium arsenite, which are inducers of HO-1, stimulated RASMC cGMP without stimulating nitrite release or inducible NO synthase expression, and the induced elevations of cGMP were not inhibited by the NO synthase inhibitor NG-methyl-L-arginine. Induced CO from RASMCs likewise caused elevation of cGMP levels in platelets coincubated with the vascular cells. Zinc protoporphyrin IX, an inhibitor of HO, reversed the inducible increases in platelet cGMP. CONCLUSIONS These results indicate that vascular SMCs have both constitutive and inducible HO activity, and they respond to specific stimuli to generate guanylyl cyclase-stimulatory CO in the same SMCs and in coincubated platelets.

[1]  M. Kroll,et al.  Control of platelet protein kinase C activation by cyclic AMP. , 1988, Biochimica et biophysica acta.

[2]  T. Gräser,et al.  Similar endothelium-independent arterial relaxation by carbon monoxide and nitric oxide. , 1989, Biomedica biochimica acta.

[3]  K. Ramos,et al.  Modulation of cyclic guanosine monophosphate levels in cultured aortic smooth muscle cells by carbon monoxide. , 1989, Biochemical pharmacology.

[4]  T. Gräser,et al.  Study on the mechanism of carbon monoxide induced endothelium-independent relaxation in porcine coronary artery and vein. , 1990, Biomedica biochimica acta.

[5]  J. Mcgrath,et al.  Carbon monoxide effects on calcium levels in vascular smooth muscle. , 1988, Life sciences.

[6]  T. Resink,et al.  Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. , 1989, Hypertension.

[7]  M. Maines Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  J. Stamler,et al.  Biochemistry of nitric oxide and its redox-activated forms. , 1992, Science.

[9]  D. Beasley,et al.  Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. , 1994, The Journal of experimental medicine.

[10]  F. Murad,et al.  Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages. , 1992, Molecular pharmacology.

[11]  S. Snyder,et al.  Carbon monoxide: a putative neural messenger. , 1993, Science.

[12]  S. Catovsky,et al.  Plasmin potentiates induction of nitric oxide synthesis by interleukin-1 beta in vascular smooth muscle cells. , 1993, The American journal of physiology.

[13]  S. Kourembanas,et al.  Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  B. Brüne,et al.  Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. , 1987, Molecular pharmacology.